TAG:
managed healthcare
Path Income Strategies Subject Of Symposium
By Robert Michel | From the Volume IV No. 13 – September 15, 1997 Issue
CEO SUMMARY: Public discussion of pathology income and compensation has been taboo for a good reason: the reality is one of contract cutbacks and declining reimbursement for pathology services. THE DARK REPORT is inviting a select group of astute pathologists to Scottsdale on November 8 t…
Joint Venture In Phoenix To Be Copied Elsewhere
By Robert Michel | From the Volume IV No. 11 – August 4, 1997 Issue
CEO SUMMARY: Look for the Quest-Sonora joint venture to be followed by others in coming months. Competition and marketplace realities are forcing the three national laboratories to respond with groundbreaking strategies. Hospital laboratory partners in these deals can reap significant ben…
Physician Management Companies Exploding, Will Transform Healthcare
By Robert Michel | From the Volume IV No. 10 – July 14, 1997 Issue
CEO SUMMARY: Consolidation and integration of healthcare services will be the dominant trend during the next five years. It happened to commercial laboratories from 1985-95. Widespread hospital consolidation began around 1990 and continues today. Now consolidation is coming to physicians….
Management Philosophy Drives UroCor’s Success
By Robert Michel | From the Volume IV No. 9 – June 23, 1997 Issue
CEO SUMMARY: In the year 1997, UroCor shows a financial strength and growth potential unlike most commercial laboratories. UroCor’s current success is a direct result of how UroCor’s management did things differently during the years from 1991 to the present. Much of UroCor’s succes…
New Hybrid Lab Systems Provide Peek At Future
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
CEO SUMMARY: As the first generation of regional laboratory systems begin operation, the marketplace is about to separate winners from losers. Stakes are high for hospital laboratory administrators. If they choose to affiliate with the wrong model, the consequences can cause extended disr…
Las Vegas Lab Gathering Debates Industry Trends
By Robert Michel | From the Volume IV No. 4 – March 10, 1997 Issue
CEO SUMMARY: Always a good forum for discussion of laboratory industry trends, this year’s meeting in Las Vegas addressed government regulation, laboratory automation and everything in between. Here is a brief rundown on some of the more interesting insights and observations….
Unilab Pushes Insurers To Increase Cap Rates
By Robert Michel | From the Volume IV No. 3 – February 17, 1997 Issue
CEO SUMMARY: California’s financially destructive capitation rates plunged two more laboratories into bankruptcy. Unilab’s actions indicate that even the largest laboratory company in the state can no longer survive without reimbursement relief. The question remains as to whether mana…
Differing Views About Capitation Rate Trends
By Robert Michel | From the Volume IV No. 3 – February 17, 1997 Issue
CEO SUMMARY: Laboratory executives in California believe that capitated rates for laboratory services in the state may soon increase. But no one knows for sure, and no documentation about specific capitation rates for newly signed laboratory services contracts has yet to become public….
“February 17, 1997 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume IV No. 3 – February 17, 1997 Issue
Meris Laboratories of San Jose, California settled government claims of Medicare and MediCal fraud with an agreement to pay $5.2 million. The announcement, on February 12, closes another whistleblower suit. MORE ON: Meris Labs… Besides the cholesterol and serum iron tests…
AmeriPath To Go Public, Files SEC Registration
By Robert Michel | From the Volume IV No. 2 – January 27, 1997 Issue
CEO SUMMARY: AmeriPath’s Initial Public Offering will make it the first publicly traded physician practice management company specializing in pathology. It represents a unique attempt to restructure traditional pathology practices to meet the needs of managed healthcare organizations….
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized